Assessment of β-human-derived chorionic gonadotrophic hormone (βhCG) and pregnancy-associated plasma protein A (PAPP-A) levels as predictive factors of preeclampsia in the first trimester among Iranian women: a cohort study
- PMID: 31801467
- PMCID: PMC6894335
- DOI: 10.1186/s12884-019-2526-x
Assessment of β-human-derived chorionic gonadotrophic hormone (βhCG) and pregnancy-associated plasma protein A (PAPP-A) levels as predictive factors of preeclampsia in the first trimester among Iranian women: a cohort study
Abstract
Background: Preeclampsia (PE) is a leading cause of maternal and perinatal mortality. There are controversial findings regarding the prediction of PE through the assessment of the Pregnancy-Associated Plasma Protein A (PAPP-A) and β-Human-Derived Chorionic Gonadotrophic hormone (βhCG) levels in the first trimester of pregnancy. Therefore, this cohort study was conducted to evaluate of PAPP-A and βhCG levels as predictive factors for PE development in the first trimester among Iranian women.
Methods: In this cohort study, a total of 4605 volunteer Primigravida and Multigravida women were selected by the census from 16 randomly selected Health Centers in Isfahan, Iran, from July 2016 to June 2018. Eligible pregnant women participated in the study had already undergone fetal anomalies screening tests between 11 + 0 and 13 + 6 weeks of pregnancy and their PAPP-A and βhCG biomarkers were adjusted to the Multiples of the Median (MOM). MOM PAPP-A < 0.4 and MOM βhCG > 3 were considered abnormal. The samples were followed up until delivery. The biomarkers' levels were compared in the two groups of women with and without PE and Relative risk (RR) and odds ratio (OR) of PE calculated.
Results: In the PE group, the mean MOM PAPP-A was significantly lower (1 vs. 1.09 with P = 0.006) and MOM βhCG was significantly higher (1.51 vs. 1.14 with P = 0.001) than the group without PE. RR and OR for PE in subjects with MOM PAPP-A < 0.4 were reported as follows: RR = 2.49, (p = 0.001) and OR = 2.09, (p = 0.001). RR and OR for PE in subjects with MOM βhCG > 3 were also reported as follows: RR = 4.02, (p = 0.001) and OR = 5.65, (p = 0.001). Adjusted OR for MOM PAPP-A < 0.4 and MOM βhCG > 3 was obtained as follows: OR = 2.09 (P = 0.001) and OR = 5.65 (P = 0.001), respectively.
Conclusion: The results of the study showed that the high levels of βhCG would cause 5.65 times increase and the low levels of PAPP-A would cause 2.09 times increase in the chance of developing PE.
Keywords: First trimester of pregnancy; NT; PAPP-A; PE; βhCG.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Role of pregnancy-associated plasma protein A (PAPP-A) and human-derived chorionic gonadotrophic hormone (free β-hCG) serum levels as a marker in predicting of Small for gestational age (SGA): A cohort study.J Res Med Sci. 2021 Nov 29;26:104. doi: 10.4103/jrms.JRMS_560_20. eCollection 2021. J Res Med Sci. 2021. PMID: 35126567 Free PMC article.
-
Prediction of Preeclampsia in Nulliparous Women according to First Trimester Maternal Factors and Serum Markers.Fetal Diagn Ther. 2020;47(4):277-283. doi: 10.1159/000503229. Epub 2019 Oct 17. Fetal Diagn Ther. 2020. PMID: 31622970
-
Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.Prenat Diagn. 2005 Oct;25(10):949-53. doi: 10.1002/pd.1251. Prenat Diagn. 2005. PMID: 16086443
-
First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.Ultrasound Obstet Gynecol. 2006 Oct;28(5):637-43. doi: 10.1002/uog.3809. Ultrasound Obstet Gynecol. 2006. PMID: 16952214 Review.
-
Obstetrical complications associated with abnormal maternal serum markers analytes.J Obstet Gynaecol Can. 2008 Oct;30(10):918-932. doi: 10.1016/S1701-2163(16)32973-5. J Obstet Gynaecol Can. 2008. PMID: 19038077 Review. English, French.
Cited by
-
Relationship between False Positive Screening Results of Down Syndrome and Adverse Pregnancy Outcomes.Iran J Nurs Midwifery Res. 2023 Jul 24;28(4):443-447. doi: 10.4103/ijnmr.ijnmr_259_21. eCollection 2023 Jul-Aug. Iran J Nurs Midwifery Res. 2023. PMID: 37694205 Free PMC article.
-
Study on the Relationship and Predictive Value of First-Trimester Pregnancy-Associated Plasma Protein-A, Maternal Factors, and Biochemical Parameters in Gestational Diabetes Mellitus: A Large Case-Control Study in Southern China Mothers.Diabetes Metab Syndr Obes. 2023 Apr 1;16:947-957. doi: 10.2147/DMSO.S398530. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 37033400 Free PMC article.
-
A Review of Roles of Uterine Artery Doppler in Pregnancy Complications.Front Med (Lausanne). 2022 Mar 3;9:813343. doi: 10.3389/fmed.2022.813343. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35308523 Free PMC article. Review.
-
Blood biomarkers to predict the onset of pre-eclampsia: A systematic review and meta-analysis.Heliyon. 2022 Nov 4;8(11):e11226. doi: 10.1016/j.heliyon.2022.e11226. eCollection 2022 Nov. Heliyon. 2022. PMID: 36387521 Free PMC article.
-
A dynamic prediction model for preeclampsia using the sFlt-1/PLGF ratio combined with multiple factors.BMC Pregnancy Childbirth. 2024 Jun 26;24(1):443. doi: 10.1186/s12884-024-06627-4. BMC Pregnancy Childbirth. 2024. PMID: 38926668 Free PMC article.
References
-
- Abdel Moety GAF, Almohamady M, Sherif NA, Raslana AN, Mohamed TF, El Moneam HMA, et al. Could first-trimester assessment of placental functions predict preeclampsia and intrauterine growth restriction? A prospective cohort study. J Matern Fetal Neonatal Med. 2016;29(3):413–417. doi: 10.3109/14767058.2014.1002763. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous